CoChat

PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK

Open access
Lu, Tao, Zou, Yanmei, Xu, Guogang, Potter, Jane A., Taylor, Garry L., Duan, Qiuhong, Yang, Qin, Xiong, Huihua, Qiu, Hong, Ye, Dawei, Zhang, Peng, Yu, Shiying, Yuan, Xianglin, Zhu, Feng, Wang, Yihua, Xiong, Hua · 2016 · Oncotarget
Cited by 22

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

// Tao Lu 2, * , Yanmei Zou 1, * , Guogang Xu 3 , Jane A. Potter 4 , Garry L. Taylor 4 , Qiuhong Duan 2 , Qin Yang 5 , Huihua Xiong 1 , Hong Qiu 1 , Dawei Ye 1 , Peng Zhang 1 , Shiying Yu 1 , Xianglin Yuan 1 , Feng Zhu 2 , Yihua Wang 6 , Hua Xiong 1 1 Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, 430030, China 2 Department of Biochemistry and molecular biology, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan, 430030, China 3 Nanlou Respiratory Department, Chinese PLA General Hospital, Beijing, 10083, China 4 BioMedical Research Complex, University of St Andrews, St Andrews, KY16 9ST, UK 5 Department of Pathology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, 430030, China 6 Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton SO17 1BJ, UK * These authors have contributed equally to this work Correspondence to: Hua Xiong, email: cnhxiong@163.com Keywords: PRIMA-1 Met , MEK, p53, colorectal cancer, tumorigenesis Received: October 17, 2015 Accepted: October 10, 2016 Published: October 27, 2016 ABSTRACT PRIMA-1 Met is the methylated PRIMA-1 (p53 reactivation and induction of massive apoptosis) and could restore tumor suppressor function of mutant p53 and induce p53 dependent apoptosis in cancer cells harboring mutant p53. However, p53 independent activity of PRIMA-1 Met remains elusive. Here we reported that PRIMA-1 Met attenuated colorectal cancer cell growth irrespective of p53 status. Kinase profiling revealed that mitogen-activated or extracellular signal-related protein kinase (MEK) might be a potential target of PRIMA-1 Met . Pull-down binding and ATP competitive assay showed that PRIMA-1 Met directly bound MEK in vitro and in cells. Furthermore, the direct binding sites of PRIMA-1 Met were explored by using a computational docking model. Treatment of colorectal cancer cells with PRIMA-1 Met inhibited p53-independent phosphorylation of MEK, which in turn impaired anchorage-independent cell growth in vitro. Moreover, PRIMA-1 Met suppressed colorectal cancer growth in xenograft mouse model by inhibiting MEK1 activity. Taken together, our findings demonstrate a novel p53-independent activity of PRIMA-1 Met to inhibit MEK and suppress colorectal cancer growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.12940

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 22

Metadata

Authors
Lu, T., Zou, Y., Xu, G., Potter, J. A., Taylor, G. L., Duan, Q., Yang, Q., Xiong, H., Qiu, H., Ye, D., Zhang, P., Yu, S., Yuan, X., Zhu, F., Wang, Y., & Xiong, H.
Venue
Oncotarget
Published
2016-10-27
Volume
7
Issue
50
Pages
83017-83030
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2543654328
Cited by
22
References
12
FWCI
1.35
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK. https://app.cochat.ai/papers/10.18632/oncotarget.12940
The paper
Lu, T., Zou, Y., Xu, G., Potter, J. A., Taylor, G. L., Duan, Q., Yang, Q., Xiong, H., Qiu, H., Ye, D., Zhang, P., Yu, S., Yuan, X., Zhu, F., Wang, Y., & Xiong, H. (2016). PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK. Oncotarget. https://doi.org/10.18632/oncotarget.12940

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.